Cernostics Announces Three Patents Addressing the TissueCypher™ Technology Platform

Cernostics, a diagnostics company delivering next generation cancer diagnostics through a unique approach to tissue analysis, announced today that the United States Patent and Trademark Office has issued two patents, US Patent 8,114,615 and US Patent... Read more

Cernostics receives 3 patents

Cancer diagnostics company Cernostics announced Tuesday it had received two patents in the United States and a third patent in Japan.... Read more
Customer Service

Mon-Fri 9am-5pm (EST)